Related Experiment Video
Updated: Aug 21, 2026

Studying Oxidative Stress Caused by the Mitis Group Streptococci in Caenorhabditis elegans
Published on: March 23, 2019
CRIF1 deficiency induces p66shc-mediated oxidative stress and endothelial activation
Harsha Nagar1, Saet-byel Jung2, Sun Kwan Kwon1
1Department of physiology, School of Medicine, Chungnam National University, Daejeon, Republic of Korea.
Insights
Mitochondrial dysfunction from CRIF1 knockdown increases oxidative stress by activating p66shc, contributing to endothelial cell activation. Targeting p66shc may mitigate this cardiovascular disease pathway.
Area of Science:
- Cardiovascular Biology
- Mitochondrial Medicine
- Cellular Stress Response
Background:
- Mitochondrial dysfunction is central to cardiovascular diseases.
- CRISPR-associated factor 1 (CRIF1) knockdown impairs mitochondrial function and elevates reactive oxygen species (ROS).
- p66shc, a redox enzyme, mediates oxidative stress in endothelial cells.
Purpose of the Study:
- To investigate if CRIF1 knockdown-induced mitochondrial dysfunction stimulates p66shc.
- To determine p66shc's role in endothelial activation under mitochondrial stress.
Main Methods:
- CRISPR-associated factor 1 (CRIF1) knockdown in endothelial cells.
- Assessed mitochondrial oxidative phosphorylation (OXPHOS) complexes, mitochondrial ROS (mtROS), and membrane potential.
- Measured p66shc phosphorylation, cytosolic ROS, and endothelial activation markers (VCAM-1, ER stress).
- Utilized p66shc knockdown to evaluate its functional impact.
Main Results:
- CRISPR-associated factor 1 (CRIF1) knockdown reduced OXPHOS, increased mtROS, and altered mitochondrial membrane potential.
- CRISPR-associated factor 1 (CRIF1) knockdown enhanced p66shc phosphorylation and cytosolic ROS production.
- CRISPR-associated factor 1 (CRIF1) knockdown upregulated VCAM-1 and ER stress markers.
- p66shc knockdown attenuated mitochondrial dysfunction, ROS production, and endothelial activation.
Conclusions:
- CRISPR-associated factor 1 (CRIF1) knockdown-induced mitochondrial dysfunction activates p66shc.
- p66shc plays a significant role in mediating endothelial activation secondary to mitochondrial dysfunction.
- These findings highlight a novel pathway linking mitochondrial health and endothelial function in cardiovascular disease.
Abstract:
Mitochondrial dysfunction has been implicated in the pathophysiology of various cardiovascular diseases. CRIF1 is a protein present in the mitochondria associated with large mitoribosomal subunits, and CRIF1 knockdown induces mitochondrial dysfunction and promotes ROS production. p66shc is a redox enzyme implicated in mitochondrial ROS generation and translation of oxidative signals and, therefore, is a key factor for oxidative stress in endothelial cells. In this study, we investigated whether mitochondrial dysfunction induced by CRIF1 knockdown induces p66shc stimulation and plays any role in mitochondrial dysfunction-induced endothelial activation. Knockdown of CRIF1 decreased the expression of mitochondrial oxidative phosphorylation (OXPHOS) complexes I, III and IV, leading to increased mitochondrial ROS (mtROS) and hyperpolarization of the mitochondrial membrane potential. Knockdown of CRIF1 also stimulated phosphorylation of p66shc and increased cytosolic ROS in endothelial cells. Furthermore, the expression of vascular cell adhesion molecule-1 and endoplasmic reticulum stress proteins were increased upon CRIF1 knockdown in endothelial cells. However, p66shc knockdown blunted the alteration in mitochondrial dynamics and ROS production in CRIF1 knockdown endothelial cells. In addition, p66shc knockdown reduced the CRIF1 knockdown-induced increases in adhesion between monocytes and endothelial cells. Taken together, these results suggest that CRIF1 knockdown partially induces endothelial activation via increased ROS production and phosphorylation of p66shc.
Related Concept Videos
Regulation of the Unfolded Protein Response
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Bioactivation and Tissue Toxicity
Coronary Artery Disease II: Pathophysiology

